Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXp Power Regulatory News (XPP)

Share Price Information for Xp Power (XPP)

Share Price is delayed by 15 minutes
Get Live Data
1,860.00    -26.00 (-1.38%)
Bid:
1,866.00
Ask:
1,886.00
Spread: 20.00 (1.072%)
Market Cap: £521.40m
XPP Live PriceLast checked at - London Stock Exchange

Intraday Xp Power Share Chart

Dividend Date Correction

12 Oct 2020 09:20

XP POWER LTD - Dividend Date Correction

XP POWER LTD - Dividend Date Correction

PR Newswire

London, October 12

12 October 2020

XP Power Limited(“XP Power” or “the Group”)

Dividend date correction

As announced with the Group’s Q3 trading update this morning, XP Power has declared a dividend for the third quarter of 20 pence per share. The record date of 15 December 2020 included in that announcement was incorrect. The dividend will in fact be paid on 15 January 2021 to shareholders on the register on 11 December 2020. All other details included in the amended announcement below remain unchanged.

Q3 Trading Update

XP Power, one of the world's leading developers and manufacturers of critical power control components to the electronics industry, is today issuing a trading update for the third quarter and nine months ended 30 September 2020 and a further update on the impact of COVID-19.

COVID-19

We are continuing to monitor the global situation in respect of COVID-19. The health, safety and well-being of our colleagues remains our first priority and we are providing our teams with our full support, following all public health advice, and complying with all government directives.

We are pleased to report that during the third quarter all of our manufacturing and logistics facilities around the world have been operating normally, with epidemic and prevention controls in place in line with all public health advice.

Trading

Revenue in the third quarter progressed positively as the exceptionally strong order intake we saw in the first half translated into product shipments. Order intake continues to be encouraging driven by demand in the Semiconductor Equipment Manufacturing sector. Healthcare orders have now returned to normal levels, following the COVID-19 related demand we saw in the first six months of 2020. Overall, orders were up 29% for the nine months ended 30 September 2020 compared with the prior year, including a £15-20 million net increase linked to COVID-19.

Production volumes from our Asian manufacturing facilities increased significantly in the third quarter as we ramped up production to meet demand. This delivered significantly increased revenues in the third quarter as we fulfilled the sizeable backlog of Healthcare and Semiconductor Equipment Manufacturing orders received during the first half. The book to bill ratio, which tracks the relationship between orders received and completed sales, was 0.82 for the third quarter (2019: 1.04) reflecting the strong production volumes and revenue growth in the period. The year-to-date book to bill is 1.16 (2019: 1.02).

£ Millions20202019ChangeChange in constant currency
Orders
Third quarter56.355.91%2%
Year to date202.1156.529%33%
Revenues
Third quarter69.053.828%32%
Year to date174.1152.714%13%
Book to Bill
Third quarter0.821.04-0.22
Year to date1.161.020.14

Financial position and dividend

Net debt at 30 September 2020 was £28.2 million, compared to £34.4 million at 30 June 2020, and the Group has immediately available committed liquidity of c.£64 million through bank facilities and cash balances (30 June 2020: c.£61 million). The Group will continue its disciplined approach to capital allocation, prioritising a strong balance sheet.

After considering the above the Board is proposing a dividend for the third quarter of 20 pence per share (2019: 20 pence per share) which will be paid on 15 January 2021 to shareholders on the register on 11 December 2020.

CEO Succession

The intention of Duncan Penny to retire as CEO at the end of 2020 and the appointment of Gavin Griggs, current CFO, as new CEO with effect from 1 January 2021, has been announced separately today.

Outlook

We enter the final quarter of 2020 in a healthy position, with an order backlog of £125.7 million (30 June 2020: £138.2 million), due to the COVID-19 related Healthcare demand experienced in the first half and the ongoing cyclical recovery of the Semiconductor Equipment Manufacturing sector. While demand across all sectors remains generally encouraging, Healthcare orders have now normalised, and we do not expect a repeat of the exceptional demand experienced earlier in the year. Our manufacturing facilities have successfully increased production to fulfil this demand, underpinning a robust third quarter revenue performance and our outlook for the final quarter.

The Board anticipates the Group’s performance for full year 2020 will be towards the top end of current analyst expectations, although we remain conscious of potential risks arising from a second wave of COVID-19 and the resultant global macroeconomic impact, and ongoing trade tensions. The Board remains confident in the long-term market opportunity for the Group, supported by the structural growth drivers in the marketplace, and in our ability to capture this opportunity.

Enquiries:

XP Power 

Duncan Penny, Chief Executive Officer +44 (0)118 976 5515

Gavin Griggs, Chief Financial Officer +44 (0)118 976 5515

Citigate Dewe Rogerson

Kevin Smith/Jos Bieneman +44 (0)207 638 9571

Note to editors

XP Power designs and manufactures power controllers, the essential hardware component in every piece of electrical equipment that converts power from the electricity grid into the right form for equipment to function.

XP Power typically designs power control solutions into the end products of major blue-chip OEMs, with a focus on the Industrial Electronics (c.33% of revenue), Healthcare (c.29% of revenue), Semiconductor Equipment Manufacturing (c.28% of revenue) and Technology (c.10% of revenue) sectors. Once designed into a programme, XP Power has a revenue annuity over the life cycle of the customer’s product which is typically 5 to 7 years depending on the industry sector.

XP Power has invested in research and development and its own manufacturing facilities in China and Vietnam, to develop a range of tailored products based on its own intellectual property that provide its customers with significantly improved functionality and efficiency.

Headquartered in Singapore and listed on the Main Market of the London Stock Exchange since 2000, XP Power is a constituent of the FTSE 250 Index. XP Power serves a global blue-chip customer base from 29 locations in Europe, North America, and Asia. 

For further information, please visit xppower.com

Date   Source Headline
4th Feb 20204:18 pmPRNHolding(s) in Company
13th Jan 20207:00 amPRNTrading Statement
13th Dec 201911:37 amPRNHolding(s) in Company
12th Dec 20194:52 pmPRNHolding(s) in Company
11th Dec 201911:23 amPRNHolding(s) in Company
10th Dec 20197:00 amPRNTrading Update
4th Dec 20197:00 amRNSAppointment of Non-Executive Director
10th Oct 20197:00 amPRNTrading Update
5th Aug 20197:00 amPRNHolding(s) in Company
2nd Aug 20196:16 pmPRNHolding(s) in Company
1st Aug 20197:00 amPRNHalf-year Report
7th May 20197:00 amPRNDirector/PDMR Shareholding
2nd May 20197:00 amPRNDirector/PDMR Shareholding
16th Apr 201911:52 amPRNResult of AGM
15th Apr 20197:00 amPRNTrading Update
19th Mar 20199:39 amRNSGrant of Long Term Incentive Plan (LTIP) awards
5th Mar 201911:33 amPRNHolding(s) in Company
5th Mar 20197:00 amPRNAnnual Results for the year ended 31 December 2018
4th Mar 20192:47 pmRNSHolding(s) in Company
4th Mar 20197:00 amPRNBlocklisting
14th Jan 20197:00 amRNSTrading Statement
3rd Jan 20198:41 amRNSConfirmation of Board Change
12th Dec 201810:00 amPRN2019 Financial Calendar
1st Nov 20184:35 pmRNSPrice Monitoring Extension
8th Oct 20187:00 amPRNTrading Statement
17th Sep 20187:15 amRNSHolding(s) in Company
22nd Aug 20187:15 amRNSHolding(s) in Company
20th Aug 20183:54 pmRNSHolding(s) in Company
14th Aug 201810:47 amPRNHolding(s) in Company
10th Aug 20187:15 amRNSNotification of Change in Director's Details
30th Jul 20187:00 amPRNHalf-year Report
10th Jul 20189:47 amPRNHolding(s) in Company
22nd Jun 20183:57 pmPRNDirector/PDMR Shareholding
15th Jun 20182:27 pmPRNDirector/PDMR Shareholding
4th Jun 20187:00 amRNSHolding(s) in Company
17th May 201810:55 amPRNDirector/PDMR Shareholding
16th May 20182:23 pmPRNDirector/PDMR Shareholding
10th May 20187:00 amPRNAcquisition(s)
1st May 20188:53 amRNSHolding(s) in Company
19th Apr 20183:27 pmRNSHolding(s) in Company
13th Apr 20187:00 amPRNTrading Statement
6th Apr 201811:10 amRNSResult of AGM (Amendment)
6th Apr 201810:35 amRNSResult of AGM
1st Mar 20187:00 amPRNFinal Results
12th Feb 20187:00 amRNS2017 Tax Update
12th Jan 20187:00 amPRNTrading Statement
20th Dec 20177:00 amRNSDirectorate Change
18th Dec 20179:13 amRNSDirector Declaration
20th Nov 20177:00 amRNSGrant of LTIP awards
31st Oct 20177:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.